Regulatory & Legal

Indonesian forestry giant APP Group holds its 'B' score in a key environmental audit. What does this mean for sustainability in a high-stakes industry?

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

A 141-km road connecting three remote First Nations in Manitoba is approved, balancing economic hopes with strict environmental oversight.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.

A new TELUS and L-SPARK partnership gives startups access to a sovereign AI supercomputer, aiming to close Canada's compute gap and fuel national innovation.

Ex-Joint Chiefs Vice Chair Admiral Grady joins Domino Data Lab's board, signaling a major push to accelerate AI for U.S. national security missions.

As sports betting ads flood the airwaves for the Super Bowl, experts warn of a hidden crisis of illegal underage gambling and equip parents to fight back.

After clearing the EU's rigorous MDR hurdle, P&F's novel heart valve system secures its European future and sets its sights on the lucrative US market.

A new affordable housing project with a public park tackles Columbus's severe housing crisis, showcasing a model for public-private urban development.

Zip US launches 'Pay in 2,' moving the BNPL model from large purchases to daily essentials like groceries, aiming to help consumers manage cash flow.

With supply chains under pressure, Flip Electronics adds TOPGUN vet David Kalinske to its board, signaling a deeper push into aerospace and defense markets.

Rio Tinto walks away from a potential $200B+ merger with Glencore, citing valuation gaps and strategic discipline. What's next for the two giants?